Trials / Unknown
UnknownNCT01409486
Screening for Early Detection and Prevention of Pompe Disease in Israel Using Tandem Mass Spectrometry
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 2 Days – 7 Days
- Healthy volunteers
- Accepted
Summary
The aim of the study is: to develop a comprehensive biochemical assay for detection of Pompe disease (glycogen storage disease type II), to be implemented in the Newborn screening program among the Israeli population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Drawing blood spots from Newborns | Dry blood spots would be taken for determination of Alpha Glucosidase activity using LC-MS-MS |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2011-08-04
- Last updated
- 2011-08-04
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01409486. Inclusion in this directory is not an endorsement.